Thyroid transcription factor-1 (TTF-1) is known to play key roles in thyroid organogenesis, in thyroid cell proliferation and in the expression of genes involved in thyroid differentiated function. Many human thyroid cancer cell lines keep producing TTF-1 despite the loss of differentiated gene expression, raising a question about the role of the factor in these cells. In order to investigate this point, we used a chimeric protein acting as a functional antagonist of TTF-1 transcriptional activity that was expressed conditionally in 8505C cells originating from an anaplastic thyroid carcinoma. We observed a growth arrest of 8505C thyroid cancer cells when the endogenous TTF-1 transcriptional activity was inhibited. It correlated with decreased levels of several mRNAs encoding positive effectors of cell proliferation like CDK1 and cyclinB1, and increased levels of various mRNAs encoding negative regulators of cell division like CDKN2B and DUSP6. In conclusion, the persistence of TTF-1 expression observed in the dedifferentiated human thyroid cancer cell line 8505C reflects the need of TTF-1 activity for the proliferation of these tumor cells.
Introduction
Thyroid transcription factor-1 (TTF-1), also known as Nkx2.1 or T/ebp, is a homeodomain protein encoded by the Titf1 gene that is present in the thyroid, in lung epithelium, in the posterior pituitary and in a few restricted areas in the brain of the adult organism (1) . In the thyroid, TTF-1 plays critical roles in organogenesis (1, 2) , in thyroid cell proliferation (3) and in the transcriptional control of genes involved in thyroid hormones synthesis (4) . Mice lacking a functional Titf1 gene fail to develop the thyroid gland (5) . Also, inactivating mutations in the human Titf1 gene have been associated with developmental and/or functional thyroid defects (6) .
Thyroid cancer is the most frequent endocrine cancer (7) . Whereas it remains often in a relatively benign form, it leads to a high death rate in its most aggressive form. Various cell lines have been derived from human thyroid tumors. Most of them present a dedifferentiated phenotype evidenced by the loss of expression of thyroid-specific genes like, thyroglobulin, thyroperoxidase and thyrotropin receptor genes (8) .
However, nearly all of these cells still express the Titf1 gene. Very recent data indicate that this is also the case in thyroid tumors in vivo (9) . The persistence of Titf1 gene expression in dedifferentiated thyroid tumor cells raises the question as to whether the presence of this transcription factor would still be required for the proliferation of these cells. In the course of a previous study of TTF-1 functions conducted in the well-differentiated rat thyroid cell line PCCl3 we gained some preliminary evidences suggesting that TTF-1 activity was required for growth in the human thyroid cancer cell lines 8505C and TPC1 (see Fig.2 and corresponding text in ref. 3) . In this work, we used the 8505C cell-line, derived from an anaplastic human thyroid carcinoma (10) , to confirm the function of the TTF-1 protein in the control of proliferation in this dedifferentiated thyroid cancer cell line. The 8505C cell line appeared indeed as a good model system for the study of TTF-1 function in completely dedifferentiated thyroid cancer cells still expressing TTF-1. Noteworthy, the overall gene expression profile of anaplastic carcinoma-derived cell-lines, like the 8505C cells, had been found to be more comparable to the molecular profile of the corresponding tumor tissue than in the case of follicular or papillary carcinomas-derived cell lines (8) . The 8505C cells thus constituded the available experimental cell system that was closest to in vivo human thyroid tumors.
Materials and methods

Cell culture
8505C cells were cultured as described in (8) at 37°C in a water-saturated 95% air/5% CO 2 atmosphere.
COS-7 cells were maintained as described before (3) .
DNA constructions and cell transformations
The controllable production of exogenous proteins in transformed 8505C cells was achieved using the Tet-Off system (Clontech) in which the expression of the transgene is silenced in the presence of doxycycline and is induced upon removal of the agent. The DNA constructs and transfection conditions used to transform the cells have been described previously (3, 11) . Human 
Microscopic examination
Microscopic examination was performed on an Eclipse TE300 inverted microscope (Nikon) and pictures were recorded using a 3CCD colour video camera XC-003P (Sony) at a magnification of 100.
Western blot analysis
Western blots were performed as described before (12) using the anti-engrailed d300 antibody from
Santa-Cruz at a dilution of 1/1,000.
Measure of cell proliferation
We used a technique developped previously ( (Fig. 1) .
Inhibiting TTF-1 activity blocks 8505C cell proliferation
Cells not expressing (in the presence of (Fig. 3A) . As shown in part B of the figure, no dramatic difference in cell proliferation was observed in the COS-7 clones expressing EngrHD or the control protein EngrHDm.
Consequences of the loss of TTF-1 activity on the mRNA population
We investigated the consequences of the We also investigated whether reducing TTF-1 in the cells affected endogenous Titf1 gene expression. We observed a slightly reduced TTF-1 mRNA level in cells expressing EngrHD as compared to non-expressing cell or to cells expressing EngrHDm, however the difference in concentrations was less than twofold in both cases (Fig. 4 , HD-dox/HD+dox and HD-dox/HDm-dox ratios).
If TTF-1 exerts a positive control on its own expression in 8505C cells, the extent of this control appears to be at least very limited. As expected, no difference was (Fig. 4 , HDm-dox/HDm+dox ratio). In our previous study in the normal rat thyroid PCCl3 cell line no effect of EngrHD expression on TTF-1 mRNA level could be detected (3).
Discussion
We Data for PCCl3 cells were gathered in a previous study (3) . Genes involved in thyroid hormone synthesis were excluded from this comparison as their expression was barely detectable in 8505C cells.
